Molina Healthcare, Inc. (NYSE:MOH) Shares Sold by Barclays PLC

Barclays PLC decreased its position in Molina Healthcare, Inc. (NYSE:MOHFree Report) by 11.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 172,617 shares of the company’s stock after selling 23,291 shares during the quarter. Barclays PLC’s holdings in Molina Healthcare were worth $50,240,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Wellington Management Group LLP increased its stake in Molina Healthcare by 7.4% during the 4th quarter. Wellington Management Group LLP now owns 2,632,232 shares of the company’s stock worth $766,111,000 after buying an additional 181,073 shares during the period. FMR LLC lifted its stake in shares of Molina Healthcare by 31.1% in the fourth quarter. FMR LLC now owns 1,801,113 shares of the company’s stock worth $524,214,000 after acquiring an additional 427,276 shares in the last quarter. Geode Capital Management LLC boosted its holdings in Molina Healthcare by 2.5% in the fourth quarter. Geode Capital Management LLC now owns 1,436,909 shares of the company’s stock valued at $417,144,000 after purchasing an additional 34,992 shares during the last quarter. Invesco Ltd. grew its stake in Molina Healthcare by 28.5% during the 4th quarter. Invesco Ltd. now owns 1,327,021 shares of the company’s stock valued at $386,229,000 after purchasing an additional 294,180 shares in the last quarter. Finally, Norges Bank purchased a new stake in Molina Healthcare during the 4th quarter worth approximately $134,675,000. Hedge funds and other institutional investors own 98.50% of the company’s stock.

Analyst Ratings Changes

A number of analysts have recently weighed in on the stock. Stephens reissued an “equal weight” rating and set a $345.00 price target on shares of Molina Healthcare in a research report on Thursday, February 6th. Wells Fargo & Company upgraded shares of Molina Healthcare from an “equal weight” rating to an “overweight” rating and upped their target price for the company from $295.00 to $372.00 in a research note on Wednesday, March 5th. StockNews.com raised Molina Healthcare from a “hold” rating to a “buy” rating in a report on Friday, April 11th. Mizuho increased their target price on Molina Healthcare from $376.00 to $400.00 and gave the stock an “outperform” rating in a report on Wednesday, April 9th. Finally, Truist Financial boosted their price target on Molina Healthcare from $340.00 to $400.00 and gave the company a “buy” rating in a report on Friday, April 11th. Nine investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $359.42.

Read Our Latest Stock Analysis on Molina Healthcare

Molina Healthcare Trading Down 3.0 %

Shares of NYSE:MOH opened at $322.57 on Friday. The company’s 50-day moving average price is $313.00 and its 200 day moving average price is $308.38. Molina Healthcare, Inc. has a fifty-two week low of $262.32 and a fifty-two week high of $370.99. The company has a market cap of $17.64 billion, a PE ratio of 15.79, a P/E/G ratio of 1.06 and a beta of 0.70. The company has a quick ratio of 1.62, a current ratio of 1.62 and a debt-to-equity ratio of 0.69.

Molina Healthcare (NYSE:MOHGet Free Report) last posted its earnings results on Wednesday, February 5th. The company reported $5.05 EPS for the quarter, missing the consensus estimate of $5.74 by ($0.69). Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. Sell-side analysts anticipate that Molina Healthcare, Inc. will post 24.4 earnings per share for the current year.

Insider Buying and Selling

In other news, Director Steven J. Orlando sold 1,000 shares of the company’s stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $301.33, for a total value of $301,330.00. Following the completion of the sale, the director now directly owns 17,375 shares of the company’s stock, valued at approximately $5,235,608.75. This represents a 5.44 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 1.26% of the company’s stock.

About Molina Healthcare

(Free Report)

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

Featured Stories

Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc. (NYSE:MOHFree Report).

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.